IL114128A0 - Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms - Google Patents

Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms

Info

Publication number
IL114128A0
IL114128A0 IL11412895A IL11412895A IL114128A0 IL 114128 A0 IL114128 A0 IL 114128A0 IL 11412895 A IL11412895 A IL 11412895A IL 11412895 A IL11412895 A IL 11412895A IL 114128 A0 IL114128 A0 IL 114128A0
Authority
IL
Israel
Prior art keywords
treatment
composition
withdrawal symptoms
nicotine craving
smoking withdrawal
Prior art date
Application number
IL11412895A
Other languages
English (en)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IL114128A0 publication Critical patent/IL114128A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
IL11412895A 1994-06-23 1995-06-13 Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms IL114128A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26455494A 1994-06-23 1994-06-23

Publications (1)

Publication Number Publication Date
IL114128A0 true IL114128A0 (en) 1995-10-31

Family

ID=23006582

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11412895A IL114128A0 (en) 1994-06-23 1995-06-13 Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms

Country Status (6)

Country Link
AU (1) AU2770895A (xx)
IL (1) IL114128A0 (xx)
MA (1) MA23587A1 (xx)
PE (1) PE41096A1 (xx)
WO (1) WO1996000070A1 (xx)
ZA (1) ZA955031B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0828489A4 (en) * 1996-03-13 2001-04-04 Univ Yale Smoking cessation treatment using naltrexone and related compounds
WO1997034605A1 (en) * 1996-03-21 1997-09-25 Mayo Foundation For Medical Education And Research Use of nicotine to treat liver disease
EP0906089B1 (en) * 1996-05-13 2003-08-27 Novartis Consumer Health S.A. Buccal delivery system
AUPO108596A0 (en) * 1996-07-18 1996-08-08 Collier, Gregory Treatment of obesity
US6165516A (en) * 1996-11-27 2000-12-26 Wm. Wrigley Jr. Company Method of controlling release of caffeine in chewing gum
JP2003509455A (ja) 1999-04-06 2003-03-11 ダブリューエム リグリー ジュニア カンパニー 医薬チューインガム製剤
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US20040234916A1 (en) 2003-05-21 2004-11-25 Alexza Molecular Delivery Corporation Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
JP4931596B2 (ja) 2003-11-07 2012-05-16 ユーエス スモークレス タバコ カンパニー リミテッド ライアビリティ カンパニー タバコ組成物
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
ES2676343T3 (es) * 2010-12-21 2018-07-18 Fertin Pharma A/S Composición de goma de mascar que comprende ácido poliacrílico reticulado
JP2023540184A (ja) * 2020-09-03 2023-09-22 ニコベンチャーズ トレーディング リミテッド 組成物及び方法
CN115590855A (zh) * 2022-10-26 2023-01-13 江南大学（Cn） 一种降低尼古丁制品中尼古丁含量的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617418C3 (de) * 1967-12-16 1980-01-24 Hoechst Ag, 6000 Frankfurt Herstellung von festen Arzneimittelformen mit verzögerter Wirkstoffabgabe
DE1901277A1 (de) * 1969-01-10 1970-08-06 Partipharm Ag Mittel zur Kompensation uebermaessigen Zigarettenkonsums
US4778677A (en) * 1981-07-09 1988-10-18 Ebbesen Gerald K Method for treatment of nicotine craving
US4568676A (en) * 1983-11-25 1986-02-04 Thomas Jefferson University Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor
DE3506406A1 (de) * 1985-02-23 1986-08-28 Hans-Josef 5600 Wuppertal Stromberg Vorrichtung zur entwoehnung von ess-, trink-, rauch- und/oder suchtgewohnheiten
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
DK365389D0 (da) * 1989-07-24 1989-07-24 Fertin Lab As Antifungalt tyggegummipraeparat
US5051426A (en) * 1990-03-27 1991-09-24 Parnell Pharmaceuticals, Inc. Method for effecting withdrawal from drug dependency
FI913526A (fi) * 1990-08-23 1992-02-24 Wrigley W M Jun Co Tuggummi med laog fukthalt.

Also Published As

Publication number Publication date
PE41096A1 (es) 1996-10-08
AU2770895A (en) 1996-01-19
WO1996000070A1 (en) 1996-01-04
MA23587A1 (fr) 1995-12-31
ZA955031B (en) 1996-02-08

Similar Documents

Publication Publication Date Title
AU2703795A (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
IL114128A0 (en) Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms
EP0713655A3 (en) Cigarette substitute and process for its manufacture
HUP9904361A3 (en) Use of isobutylgaba and its derivatives for the treatment of pain
EP0632969A3 (de) Filtertow und Verfahren zu dessen Herstellung sowie Tabakrauchfilterelement und Verfahren zu dessen Herstellung.
EP0777473A4 (en) PREPARATIONS AND METHOD FOR CONTROLLING SMOKING
IL114129A0 (en) Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms
ZA938094B (en) Process for adjesting the moisture content of tobacco
EP0632968A3 (de) Filtertow und Verfahren zu dessen Herstellung sowie Tabakrauchfilterelement und Verfahren zu dessen Herstellung.
IL126683A0 (en) Pharmaceutical composition and method for the treatment of severe blood loss and for the inhibition or treatment of hemorrhagic shock
IL114130A0 (en) Composition for the treatment of nicotine craving and/or smoking withdrawal symptoms
GB9404707D0 (en) Filter for smoking article and smoking article incorporating it
EP0496148A3 (en) Improvements in the treatment of ashes
AU8096094A (en) Use of nicotine substitutes for the treatment of nicotine withdrawal
GB2222066B (en) Method of increasing the hardness of cigarette filter elements
GB9410482D0 (en) Tobacco smokers' mouthpiece
AU3879789A (en) Use of benzo(g)quinolines in treatment of nicotine addiction
AU2446895A (en) Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers
AU2100188A (en) Nicotine level reduction in cigarettes
GB9304027D0 (en) Packet for blocks of cigarettes and the like
ZA959717B (en) Tobacco rod and/or filter for smoking article
IL110749A0 (en) Smoker's device for reducing the consumption of cigarettes
AU2107097A (en) Smoking mixture for use in the treatment of drug dependency
GB9325247D0 (en) Smokers'ashtray
HUP9601880A3 (en) Cigarette short of nicotine